These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34650914)
1. OLFML2A Downregulation Inhibits Glioma Proliferation Through Suppression of Wnt/β-Catenin Signaling. Ma S; Duan L; Dong H; Ma X; Guo X; Liu J; Li G; Yu Y; Xu Y; Yuan G; Zhao X; Tian G; Zhai S; Pan Y; Zhang Y Front Oncol; 2021; 11():717917. PubMed ID: 34650914 [TBL] [Abstract][Full Text] [Related]
2. CUX1 Facilitates the Development of Oncogenic Properties Feng F; Zhao Z; Zhou Y; Cheng Y; Wu X; Heng X Front Mol Biosci; 2021; 8():705008. PubMed ID: 34422906 [No Abstract] [Full Text] [Related]
3. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling. Zhang D; Guo S; Wang H; Hu Y Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/β-catenin signaling by targeting fibroblast growth factor 19. Zhang L; Cao Y; Jia D; Wei M Biochem Biophys Res Commun; 2019 Apr; 511(3):619-625. PubMed ID: 30826062 [TBL] [Abstract][Full Text] [Related]
5. PAX3 Promotes Proliferation of Human Glioma Cells by WNT/β-Catenin Signaling Pathways. Liang X; Dong Z; Bin W; Dekang N; Xuhang Z; Shuyuan Z; Liwen L; Kai J; Caixing S J Mol Neurosci; 2019 May; 68(1):66-77. PubMed ID: 30826985 [TBL] [Abstract][Full Text] [Related]
6. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway. Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044 [TBL] [Abstract][Full Text] [Related]
7. LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway. Gong X; Liao X; Huang M Pathol Res Pract; 2019 Mar; 215(3):564-570. PubMed ID: 30661904 [TBL] [Abstract][Full Text] [Related]
8. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients. Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway. Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296 [TBL] [Abstract][Full Text] [Related]
10. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7. Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177 [TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth. Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990 [TBL] [Abstract][Full Text] [Related]
12. GeneChip expression profiling identified Gao X; Yang Z; Xu C; Yu Q; Wang M; Song J; Wu C; Chen M Ann Transl Med; 2022 Mar; 10(6):274. PubMed ID: 35433966 [TBL] [Abstract][Full Text] [Related]
13. The expressions of Wnt/β-catenin pathway-related components in brainstem gliomas. Wu W; Tian Y; Wan H; Song Y; Li J; Zhang L Can J Neurol Sci; 2013 May; 40(3):355-60. PubMed ID: 23603171 [TBL] [Abstract][Full Text] [Related]
14. Tunicamycin inhibits progression of glioma cells through downregulation of the MEG-3-regulated wnt/β-catenin signaling pathway. Li X; Xue L; Peng Q Oncol Lett; 2018 Jun; 15(6):8470-8476. PubMed ID: 29805584 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Pu P; Zhang Z; Kang C; Jiang R; Jia Z; Wang G; Jiang H Cancer Gene Ther; 2009 Apr; 16(4):351-61. PubMed ID: 18949017 [TBL] [Abstract][Full Text] [Related]
16. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma. Ni H; Ji D; Li J; Zhao Z; Zuo J Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591 [TBL] [Abstract][Full Text] [Related]
17. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway. Xia S; Ji R; Zhan W BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755 [TBL] [Abstract][Full Text] [Related]
19. Coronin 3 Promotes the Development of Oncogenic Properties in Glioma Through the Wnt/β-Catenin Signaling Pathway. Wang M; Li Q; Yu S; Zhang Z; Qiu P; Zhang Y; Yang W; Xu G; Xu T Onco Targets Ther; 2020; 13():6661-6673. PubMed ID: 32764958 [TBL] [Abstract][Full Text] [Related]
20. BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells. Tian T; Guo T; Zhen W; Zou J; Li F Cell Death Dis; 2020 Oct; 11(10):900. PubMed ID: 33093476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]